Find Paid Clinical Trials in Denmark

Paid Clinical Trials and Focus Groups

Find Paid Clinical Trials

Paid Clinical Trials in Denmark




  • Condition:   Inflammatory Bowel Disease
    Interventions:   Drug: Monofer;   Drug: Iron Sulphate
    Sponsors:   Pharmacosmos A/S;   Max Neeman International
    Recruiting - verified November 2009

  • Condition:   Cancer of the Head and Neck
    Intervention:   Other: 18F-FAZA
    Sponsors:   University of Aarhus;   Danish Head and Neck Cancer Group
    Recruiting - verified November 2009

  • Condition:   Malignant Lymphoma
    Interventions:   Drug: r-metHuSCF and Filgrastim;   Drug: r-metHuSCF and Filgrastim;   Drug: Chemotherapy plus Filgrastim
    Sponsors:   Aalborg Hospital;   Herlev Hospital;   Rigshospitalet, Denmark;   Helsinki University Central Hospital;   Turku University Hospital;   University Hospital, Linkoeping;   Umeå University;   Radiumhospitalet Oslo Norway;   Nordic Lymphoma Group;   Amgen
    Suspended - verified November 2009

  • Conditions:   Mediastinal Tumours and Lymph Nodes;   Celiac, Perigastric and Peri-pancreatic Lymph Nodes;   Pancreatic Masses;   Liver Masses;   Adrenal Masses
    Intervention:  
    Sponsors:   University Hospital, Gentofte, Copenhagen;   University of Medicine and Pharmacy Craiova;   Allgemeines Krankenhaus Celle, Celle, Germany;   Pathologic Institute, Wittinger Strasse, Celle, Germany;   Sana Hospital Lübeck GmbH, Lübeck, Germany;   Hospital Grosshansdorf, Grosshandorf, Germany;   Medical University Schleswig-Holstein, Luebeck, Germany
    Recruiting - verified November 2009

  • Conditions:   Overweight;   Physical Condition;   Musculoskeletal Diseases;   Workability;   Sick-leave
    Interventions:   Behavioral: Intervention-group;   Behavioral: Control-group
    Sponsors:   University of Copenhagen;   The Danish Working Environment Research Foundation;   The Ministry of Culture Committee on Sports Research, Denmark
    Enrolling by invitation - verified November 2009

  • Conditions:   Eczema;   Dermatitis;   Skin Disease
    Intervention:   Behavioral: A randomised clinical trial of the effect of classification and individual counselling
    Sponsors:   Roskilde County Hospital;   The Danish Working Environment Authority;   Region Zealand Health Scientific Research Foundation
    Recruiting - verified November 2009

  • Condition:   Obesity
    Intervention:   Other: 1-hour video game play
    Sponsors:   University of Copenhagen;   Nordea Foundation
    Recruiting - verified November 2009

  • Condition:   Diabetes Mellitus, Type 2
    Intervention:   Drug: BI 10773
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Recruiting - verified November 2009

  • Condition:   Liver Transplantation
    Interventions:   Drug: Advagraf;   Drug: Mycophenolate Mofetil;   Drug: Basiliximab;   Drug: Corticosteroids
    Sponsor:   Astellas Pharma Inc
    Recruiting - verified November 2009

  • Condition:   H1N1v Influenza
    Interventions:   Biological: Focetria;   Biological: Focetria;   Biological: Focetria;   Biological: Focetria
    Sponsors:   Copenhagen Studies on Asthma in Childhood;   Novartis
    Recruiting - verified November 2009

  • Conditions:   Postoperative Pain;   Analgesic Efficacy
    Interventions:   Drug: 20 mL ropivacaine 5 mg/mL;   Drug: 10 mL ropivacaine 10 mg/mL
    Sponsor:   Lundbeck Foundation
    Completed - verified November 2009

  • Condition:   Diabetes Mellitus, Type 2
    Interventions:   Behavioral: dietary treatment;   Behavioral: dietary treatment
    Sponsor:   Hospitalsenheden Vest
    Recruiting - verified November 2009

  • Conditions:   Infection;   Hip Replacement Arthroplasty
    Intervention:   Procedure: Cementless one-stage surgical revision
    Sponsor:   University of Aarhus
    Recruiting - verified November 2009

  • Condition:   Lymphocytic Leukemia, Chronic
    Interventions:   Drug: RO5072759;   Drug: rituximab;   Drug: chlorambucil
    Sponsors:   Hoffmann-La Roche;   Genentech
    Not yet recruiting - verified November 2009

  • Condition:   Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
    Intervention:   Drug: Subcutaneous immunoglobulin
    Sponsors:   University of Aarhus;   Baxter Healthcare Corporation;   GCP-unit at Aarhus University Hospital, Aarhus, Denmark
    Not yet recruiting - verified November 2009

  • Condition:   HIV Infections
    Intervention:   Biological: peptide vaccine (AFO-18)
    Sponsors:   Hvidovre University Hospital;   Statens Serum Institut;   Rigshospitalet, Denmark;   Ministry of the Interior and Health, Denmark
    Enrolling by invitation - verified November 2009

  • Condition:   Type 2 Diabetes
    Intervention:   Device: Electronic feedback system on diabetes care
    Sponsor:   University of Aarhus
    Completed - verified November 2009

  • Condition:   Diabetes Mellitus, Type 2
    Interventions:   Drug: NN5401;   Drug: biphasic insulin aspart 30
    Sponsor:   Novo Nordisk
    Recruiting - verified November 2009

  • Condition:   Lymphoma, Large-Cell, Diffuse
    Interventions:   Drug: RITUXIMAB + DHAP;   Drug: RITUXIMAB + DVD;   Drug: OFATUMUMAB + DVD;   Drug: OFATUMUMAB + DHAP
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified November 2009

  • Condition:   Rheumatoid Arthritis
    Interventions:   Drug: tocilizumab;   Drug: tocilizumab;   Drug: methotrexate
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • Condition:   Musculoskeletal Diseases
    Interventions:   Behavioral: Physical activity and Health check;   Behavioral: Health check only
    Sponsor:   University of Southern Denmark
    Enrolling by invitation - verified November 2009

  • Condition:   Atopic Dermatitis
    Intervention:   Behavioral: Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bl-07
    Sponsor:   University of Copenhagen
    Terminated - verified November 2009

  • Conditions:   Depression;   Stress
    Interventions:   Drug: Rhodiola rosea, L;   Drug: Rhodiola rosea, L., Eleutherococcus senticosus, Schisandra chinensis;   Drug: Panax ginseng;   Drug: Placebo - dark brown sugar
    Sponsor:   Frederiksberg University Hospital
    Recruiting - verified November 2009

  • Condition:   Type 2 Diabetes Mellitus
    Interventions:   Drug: Saxagliptin;   Drug: Glimepiride
    Sponsors:   AstraZeneca;   Bristol-Myers Squibb
    Recruiting - verified November 2009

  • Condition:   Bruxism
    Interventions:   Device: Grindcare;   Device: Grindcare - inactive
    Sponsor:   Medotech A/S
    Recruiting - verified October 2009

  • Conditions:   Deglutition Disorders;   Cognitive Functions;   Physical Function in Daily Activities;   Levels of Frailty;   Respiratory Tract Infections
    Intervention:  
    Sponsor:   Herlev Hospital
    Not yet recruiting - verified October 2009

  • Condition:   Non Small Cell Lung Cancer
    Interventions:   Drug: Pemetrexed;   Drug: Cisplatin;   Drug: Bevacizumab
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009

  • Conditions:   Preoperative;   Exercise;   Osteoarthritis;   Joint Replacement
    Intervention:   Other: Preoperative neuromuscular exercise
    Sponsors:   University of Southern Denmark;   Odense University Hospital Svendborg Sygehus;   Odense University Hospital
    Not yet recruiting - verified October 2009

  • Condition:   Liver Cirrhosis
    Intervention:  
    Sponsor:   Aarhus University Hospital
    Not yet recruiting - verified October 2009

  • Conditions:   Prostate Cancer;   Metastasis
    Intervention:   Drug: ZD4054
    Sponsors:   Aarhus University Hospital;   Copenhagen Trial Unit, Center for Clinical Intervention Research
    Not yet recruiting - verified October 2009

  • Conditions:   Temporomandibular Disorder;   Headache
    Intervention:   Device: Grindcare® (Biofeedback)
    Sponsor:   Medotech A/S
    Recruiting - verified October 2009

  • Condition:   Acromegaly
    Intervention:  
    Sponsor:   University of Aarhus
    Active, not recruiting - verified October 2009
  • Find Paid Clinical Trials